March 16th-17th, Budapest
Harnessing electronic health records and real world evidence to create new therapies more efficiently is quickly becoming a reality. How do we maximize the benefits offered by harnessing available health data while solving issues around its reuse and work with regulators to provide the right evidence?.
Supported by:
March 23, 2016
This webinar will provide the opportunity for participants to receive the latest updates on key outputs from the IMI GetReal project. Part of the IMI GetReal project has focused on exploring how best to tackle effectiveness research before marketing authorisation.
March 8, 2016
In contrast, EMIF has brought together a group of people that enabled identification of the right cohorts through the cohort selection tool, or the EMIF catalogue. In a study that we’re doing at the moment we’ve already completed a study of 500 individuals and we’re now embarking on a study of 1000 individuals.
March 8, 2016 If you can gather all this data together – from historical data i.e. disease history, to the ‘omics’ data and genetic data – we could, for instance, develop a web-based service where patients could see how their past and current lifestyle decisions affect their disease risks. For example, if a patient knows he has a higher risk for smoking-induced cancer, that might motivate him to stop smoking – or if he has a genetic tendency to become obese in later life, then maybe that will motivate him to follow a healthier lifestyle.
March 8, 2016 Patient data, at the end of the day, belongs to individual people. We are sensitive to that and I think having the input of an independent external ethical advisory board shows just how careful we are being, which is important for the public to know. Having convened that group and meeting with them regularly is a very big step forward.
April 18, 2016
The webinar will introduce the concept of drivers of effectiveness and will provide an overview of the methods which can be used to identify them early during the drug development plan.
May 10, 2016
This webinar on “Synthesis and integration of real-world evidence in network meta-analyses and outcome prediction” will give the participants an understanding of important methodological key deliverables achieved by the IMI GetReal team.
February 7, 2016
When asked about the issues around harnessing health data in Europe in Washington DC on October 27th, Prof Hans Georg Eichler, Senior Medical Officer of the European Medicines Agency responded, "I come from an area with hysterical data protection.”[1] Why would a regulator feel this way? Surely, Europe’s public health systems have access to health data that is second to none?
January 27, 2016
When it comes to sharing health data, solving the technical solutions of data sharing is more straightforward than structuring workable collaboration models that satisfy both data owners and researchers alike, says Bart Vannieuwenhuyse, Senior Director Health Information Sciences, Janssen Pharmaceutica; Coordinator EMIF.
December 14, 2015
Europe’s world-leading science base is fuelling innovation in advanced therapies, which a growing volume of clinical data indicates will address a diversity of unmet medical needs, delivering better health and generating economic benefits.
